Medicine and Dentistry
Human Immunodeficiency Virus 1
100%
Protein
60%
Virus Infectivity
60%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3G
50%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3F
40%
CD4+ T Lymphocyte
20%
T Cell
20%
Pathogenesis
10%
Host Cell
10%
Retroviridae
10%
Immunity
10%
Simian Immunodeficiency Virus
10%
Aciclovir
10%
Analysis
10%
Pathogen
10%
Family
10%
Pharmacology, Toxicology and Pharmaceutical Science
Human Immunodeficiency Virus 1
100%
Protein
60%
Virus Infectivity
60%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3G
50%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3F
40%
Human
10%
Rhesus Monkey
10%
DNA
10%
Pathogenesis
10%
Aciclovir
10%
Simian Immunodeficiency Virus
10%
Infectious Agent
10%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Virus Infectivity
60%
APOBEC3G
50%
CD4+ T Lymphocyte
20%
Immunity
10%
Degradation
10%
Retrovirus
10%
Host Cell
10%
Rhesus Monkey
10%
Simian Immunodeficiency Virus
10%
Human
10%
Infectious Agent
10%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Virus Infectivity
60%
APOBEC3G
50%
APOBEC3F
40%
Immunity
10%
Degradation
10%
Human
10%
Rhesus Monkey
10%
Simian Immunodeficiency Virus
10%
Infectious Agent
10%
Neuroscience
Protein
60%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3G
50%
Apolipoprotein B Messenger RNA Editing Enzyme Catalytic Polypeptide 3F
40%
DNA
10%
Aciclovir
10%